Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/17/2023 | 42.63% | BTIG | → $45 | Initiates Coverage On | → Buy |
04/12/2023 | 39.46% | B of A Securities | → $44 | Initiates Coverage On | → Neutral |
02/27/2023 | 90.17% | Lake Street | $40 → $60 | Maintains | Buy |
12/19/2022 | 26.78% | Lake Street | → $40 | Initiates Coverage On | → Buy |
09/21/2022 | — | William Blair | Initiates Coverage On | → Outperform | |
08/08/2022 | 80.67% | Barclays | $50 → $57 | Maintains | Equal-Weight |
08/12/2021 | 191.6% | Barclays | → $92 | Initiates Coverage On | → Equal-Weight |
What is the target price for Apollo Medical Hlgs (AMEH)?
The latest price target for Apollo Medical Hlgs (NASDAQ: AMEH) was reported by BTIG on October 17, 2023. The analyst firm set a price target for $45.00 expecting AMEH to rise to within 12 months (a possible 42.63% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Apollo Medical Hlgs (AMEH)?
The latest analyst rating for Apollo Medical Hlgs (NASDAQ: AMEH) was provided by BTIG, and Apollo Medical Hlgs initiated their buy rating.
When is the next analyst rating going to be posted or updated for Apollo Medical Hlgs (AMEH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apollo Medical Hlgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apollo Medical Hlgs was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
Is the Analyst Rating Apollo Medical Hlgs (AMEH) correct?
While ratings are subjective and will change, the latest Apollo Medical Hlgs (AMEH) rating was a initiated with a price target of $0.00 to $45.00. The current price Apollo Medical Hlgs (AMEH) is trading at is $31.55, which is within the analyst's predicted range.